Solace VR for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Cedars-Sinai Medical Center, Los Angeles, CA
Chronic Pain
VR Solace - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to assess the therapeutic response to VR Solace in patients with chronic pain and anxiety using real-time clinical and survey data. Regression analysis of demographic characteristics, lab and survey data will be conducted to better understand the efficacy of VR Solace in treating chronic pain and anxiety. The investigator also aims to explore the possible association between the patient-reported changes in pain or anxiety levels with real-time physiological changes observed during VR Solace use.

Treatment Effectiveness

Study Objectives

4 Primary · 4 Secondary · Reporting Duration: The last minute of VR Solace use

15 minutes after the VR session (post-study completion)
Patient-reported anxiety level post-VR session
Patient-reported pain level post-VR session
Baseline
Patient-reported anxiety level pre-VR session
Patient-reported pain level pre-VR session
The first minute and the last minute of VR Solace use
Heart rate variability
Pupil diameter variability
The last minute of VR Solace use
Average heart rate
Pupil diameter

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

Solace VR
1 of 1
Experimental Treatment

34 Total Participants · 1 Treatment Group

Primary Treatment: Solace VR · No Placebo Group · Phase 2

Solace VR
Device
Experimental Group · 1 Intervention: VR Solace · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: the last minute of vr solace use
Closest Location: Cedars-Sinai Medical Center · Los Angeles, CA
Photo of Los Angeles  1Photo of Los Angeles  2Photo of Los Angeles  3
2006First Recorded Clinical Trial
5 TrialsResearching Chronic Pain
514 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You endorse pain/anxiety with objective measurement of 3 or greater on 10-point scale on validated survey.
You have a diagnosis of chronic pain or anxiety.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.